By Rockies Venture Club | RVC Weekly Newsletter July 3
The Five Fallacies of Life Science Investing
I’m always interested to see how angels and angel groups present themselves to the public with regard to what kinds of companies they would like to review. One group proudly claimed that “we do anything except for life science.” Upon further inquiry, it turned out that this group had succumbed to the fallacies of life science investing and they were missing out on big opportunities.
An analysis of venture capital returns by vertical done by PitchBook concluded that “life sciences deals outperform other sectors on an adjusted basis, despite a risky reputation.”
At RVC, Life Sciences are one of our three focus areas (Life Science, CleanTech, and Technology/CPG.) Life Sciences make up about a third of our portfolio and have had more returns by sector for RVC investors than other verticals. Surprisingly, this…
Click here to view original post
